Scarica l'app Stockscreener
36.95
2.15%
-0.81
Precedente Chiudi:
$37.76
Aprire:
$37.88
Volume 24 ore:
1.03M
Relative Volume:
0.99
Capitalizzazione di mercato:
$2.85B
Reddito:
$13.17M
Utile/perdita netta:
$-199.06M
Rapporto P/E:
-13.49
EPS:
-2.74
Flusso di cassa netto:
$-156.53M
1 W Prestazione:
+2.04%
1M Prestazione:
-1.10%
6M Prestazione:
+5.75%
1 anno Prestazione:
-9.41%
Intervallo 1D:
$36.85
$37.88
Intervallo di 1 settimana:
$35.60
$37.99
Portata 52W:
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Nome
Xenon Pharmaceuticals Inc
Settore
Industria
Telefono
(604) 484-3300
Indirizzo
200 - 3650 GILMORE WAY, BURNABY
Confronta XENE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
36.95 | 2.91B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Ripresa | Wells Fargo | Overweight |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-10-01 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-04 | Iniziato | Citigroup | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-04-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-14 | Iniziato | Goldman | Buy |
| 2022-12-12 | Iniziato | Cowen | Outperform |
| 2022-11-28 | Iniziato | Wells Fargo | Overweight |
| 2022-10-19 | Iniziato | Raymond James | Outperform |
| 2022-08-29 | Iniziato | BofA Securities | Buy |
| 2022-07-21 | Iniziato | JP Morgan | Overweight |
| 2021-10-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-10-02 | Iniziato | SVB Leerink | Outperform |
| 2020-07-21 | Iniziato | Needham | Buy |
| 2020-06-01 | Ripresa | Jefferies | Buy |
| 2020-03-25 | Iniziato | Wedbush | Outperform |
| 2020-01-08 | Iniziato | William Blair | Outperform |
| 2019-09-20 | Iniziato | Guggenheim | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2017-03-13 | Iniziato | Jefferies | Buy |
| 2016-10-21 | Iniziato | Stifel | Buy |
| 2016-09-26 | Iniziato | Guggenheim | Buy |
| 2016-04-14 | Reiterato | Jefferies | Buy |
| 2015-10-30 | Ripresa | Jefferies | Buy |
| 2014-12-02 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie
Long term hold vs stop loss in Xenon Pharmaceuticals Inc.2025 Technical Overview & Weekly High Return Forecasts - newser.com
Combining machine learning predictions for Xenon Pharmaceuticals Inc.Trade Risk Assessment & Capital Efficiency Focused Ideas - newser.com
Is Xenon Pharmaceuticals Inc. meeting your algorithmic filter criteriaJuly 2025 Action & Long-Term Growth Stock Strategies - newser.com
Xenon Pharmaceuticals Inc. stock daily chart insights2025 Geopolitical Influence & Community Verified Trade Signals - newser.com
Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - MarketBeat
Exit strategy if you’re trapped in Xenon Pharmaceuticals Inc.Sell Signal & AI Enhanced Trading Signals - newser.com
What indicators show strength in Xenon Pharmaceuticals Inc.July 2025 Recap & AI Based Trade Execution Alerts - newser.com
Aug Decliners: Does Xenon Pharmaceuticals Inc. align with a passive investing strategyPortfolio Value Report & Risk Controlled Swing Trade Alerts - khodrobank.com
Should you hold or exit Xenon Pharmaceuticals Inc. nowJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Fund Flows: Is Xenon Pharmaceuticals Inc forming a bullish divergence2025 Risk Factors & Accurate Technical Buy Alerts - khodrobank.com
Harbor Capital Advisors Inc. Reduces Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Can momentum traders help lift Xenon Pharmaceuticals Inc.2025 Market Overview & Real-Time Volume Analysis - newser.com
Does Xenon Pharmaceuticals Inc. show high probability of rebound2025 Valuation Update & Precise Buy Zone Identification - newser.com
Quarterly Earnings: Is Xenon Pharmaceuticals Inc a speculative investmentJuly 2025 Macro Moves & Community Consensus Trade Alerts - khodrobank.com
Volume spikes in Xenon Pharmaceuticals Inc. stock – what they meanGold Moves & Fast Exit Strategy with Risk Control - newser.com
Xenon Pharmaceuticals Inc. stock chart pattern explainedPortfolio Value Report & Verified Chart Pattern Signals - newser.com
Entry Recap: Is Xenon Pharmaceuticals Inc stock undervalued right nowExit Point & Scalable Portfolio Growth Methods - khodrobank.com
Breakout Move: Is Xenon Pharmaceuticals Inc a strong candidate for buy and holdQuarterly Earnings Report & Daily Oversold Bounce Ideas - khodrobank.com
Bear Alert: Is ANGPRD a good ESG investmentMarket Sentiment Summary & Capital Protection Trade Alerts - خودرو بانک
Analyst Upgrade: Is Xenon Pharmaceuticals Inc a speculative investmentMarket Sentiment Summary & Stock Timing and Entry Methods - خودرو بانک
Using data models to predict Xenon Pharmaceuticals Inc. stock movement2025 Retail Activity & Safe Capital Growth Tips - newser.com
Alliancebernstein L.P. Cuts Stock Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Parkman Healthcare Partners LLC Sells 18,428 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Design Therapeutics Appoints Justin Gover to Board of Directors - The Globe and Mail
Alyeska Investment Group L.P. Has $12.32 Million Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report? - Yahoo Finance
RSI and MACD Indicate Shift in Xenon Pharmaceuticals Inc. Sentiment - beatles.ru
Trapped Investors in Xenon Pharmaceuticals Inc. Await Breakout Signal2025 Valuation Update & Community Verified Swing Trade Signals - beatles.ru
Traders Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat
ADAR1 Capital Management LLC Buys 77,001 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Price momentum metrics for Xenon Pharmaceuticals Inc. explainedDividend Hike & AI Driven Stock Price Forecasts - Newser
How to build a custom watchlist for Xenon Pharmaceuticals Inc.July 2025 Update & Free Long-Term Investment Growth Plans - Newser
Vestal Point Capital LP Purchases 490,000 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Braidwell LP Decreases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Can Xenon Pharmaceuticals Inc. sustain its profitabilityJuly 2025 Movers & Fast Gaining Stock Strategy Reports - خودرو بانک
What is Xenon Pharmaceuticals Inc.’s market positionMarket Risk Report & Stepwise Entry and Exit Trade Signals - خودرو بانک
Can swing trading help recover from Xenon Pharmaceuticals Inc. lossesRisk Management & Daily Risk Controlled Trade Plans - Newser
Chart based analysis of Xenon Pharmaceuticals Inc. trends2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - Newser
Understanding Xenon Pharmaceuticals Inc.’s price movementWeekly Trend Summary & Entry Point Confirmation Signals - Newser
Building trade automation scripts for Xenon Pharmaceuticals Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
Is Xenon Pharmaceuticals Inc. a speculative investmentTrade Analysis Summary & Low Drawdown Investment Strategies - خودرو بانک
Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Xenon Pharmaceuticals Inc Azioni (XENE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GANNON STEVEN | Director |
Jun 05 '25 |
Sale |
30.48 |
3 |
91 |
7,141 |
| GANNON STEVEN | Director |
May 14 '25 |
Option Exercise |
12.57 |
5,144 |
64,660 |
7,144 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Option Exercise |
17.76 |
22,468 |
399,032 |
53,770 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Option Exercise |
17.76 |
16,315 |
289,754 |
46,468 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Option Exercise |
17.76 |
16,217 |
288,014 |
47,519 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Sale |
40.20 |
22,468 |
903,214 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Sale |
40.50 |
16,315 |
660,806 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Sale |
40.08 |
16,217 |
649,977 |
31,302 |
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):